Table 1 Patient characteristics
CK hFSRT | nFSRT | |
|---|---|---|
CKC (blinded) | 49 | 0 |
CKC (blinded) | 156 | 0 |
RT (blinded) | 0 | 136 |
Age [y], median (range) | 57 (27–86) | 58 (20–84) |
DOTATOC PET RT-planning | 6 (2.9%) | 6 (4.4%) |
Total dose [Gy], median (range) | 25 (5–61) | 59.4 (32.4–63) |
Class algorithm: Low risk group, n (%) | 6 (3%) | 2 (1.5%) |
Class algorithm Intermediate risk group, n (%) | 12 (5.9%) | 10 (7.4%) |
Class algorithm High risk group, n (%) | 184 (91.1%) | 124 (91.2%) |
Median follow-up | 32.5 (2–135) | 41.5 (1–232) |
Definitive radiotherapy at first diagnosis | 135 (65.9%) | 57 (41.9%) |
Adjuvant radiotherapy at first diagnosis | 16 (7.8%) | 34 (25%) |
Definitive radiotherapy at relapse | 54 (26.3%) | 45 (33.1%) |
No surgery | 135 (65.9%) | 52 (38.2%) |
Biopsy | 6 (2.9%) | 5 (3.7%) |
Subtotal resection | 37 (18.0%) | 52 (38.2%) |
Gross total resection | 25 (12.2%) | 18 (13.2%) |
Resectional status unclear | 2 (1.0%) | 9 (6.6%) |
Previous RT | 4 (2.0%) | 1 (0.7%) |